IGBA Position on Identification of Biological, including Biosimilar Medicines 2018 Update of Facts & Figures

IGBA Position on Identification of Biological, including Biosimilar Medicines 2018 Update of Facts & Figures.

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on: Twitter - LinkedIn - YouTube

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.
I accept cookies from this site Agree